Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (1666)	11/11/1998 3:02:00 PM
From: Rudy Saucillo	Read Replies (1) of 2742

I don't really know but I'll take a guess: selling part (the reagents business) or all of the company is probably the top priority. Secondly, they're probably searching for therapeutics or diagnostics to in-license that will complement their own products/licenses. Generally speaking, I think they want to become a therapeutics company - either alone or as a merged outfit. I think the next serious price pop will be when something like this becomes a reality. Rudy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next